• OPEN AN ACCOUNT
Indian Indices
Sensex
76,152.86 -417.49
( -0.55%)
Global Indices
Nasdaq
53,087.25 299.37
(0.57%)
Dow Jones
7,688.45 35.98
(0.47%)
Hang Seng
64,337.38 11.74
(0.02%)
Nikkei 225
10,761.93 -27.35
(-0.25%)
Forex
USD-INR
94.95 -0.29
(-0.30%)
EUR-INR
110.11 -0.38
(-0.35%)
GBP-INR
128.48 -0.52
(-0.40%)
JPY-INR
0.59 0.00
(-0.47%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
629.4942217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
81.81
245080.59
EPS(TTM)
Face Value()
Div & Yield %
112.85
2
0.32
 

nbcc (india) ltd
Amerise Biosciences standalone net profit declines 45.45% in the March 2026 quarter
May 06,2026
Net profit of Amerise Biosciences declined 45.45% to Rs 0.06 crore in the quarter ended March 2026 as against Rs 0.11 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 100.00% to Rs 0.02 crore in the year ended March 2026 as against Rs 0.01 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.